DrFirst.com

DrFirst.com

DrFirst traces its origins to 2000, when James F. Chen founded the firm in Rockville, Maryland, after witnessing the clinical consequences of illegible prescriptions and poor medication reconciliation. Chen, a technologist with no clinical background, approached the problem as a data-integration challenge rather than a pure software build — a posture that would define the company's architecture. Over two decades, DrFirst grew quietly beyond e-prescribing into medication management, price transparency, and care collaboration, serving health systems, pharmacies, and payers without attempting to replace the electronic health records they already ran. The firm's early decision to embed its tools inside existing clinical workflows — rather than selling a standalone application — created a switching-cost advantage that persists across its install base. DrFirst's product suite spans four primary domains: medication management, clinical workflow automation, care collaboration, and patient engagement. The firm's core asset, Backline, functions as a HIPAA-compliant messaging and care-coordination layer that connects providers across disparate EHR instances — effectively a clinical middleware. In addition, DrFirst operates a real-time prescription benefit tool, RxInform, that surfaces out-of-pocket drug costs at the point of care, and a medication history platform, iPrescribe, that aggregates patient pharmacy data. Confirmed integration partners include Cerner, Epic, and Allscripts, per the firm's public documentation. The firm generates revenue through SaaS subscriptions, transaction fees on e-prescriptions routed through its network, and professional services tied to EHR integration and regulatory compliance. Geographically, its footprint is concentrated in the United States, with particular density among ambulatory practices and mid-sized health systems that lack the internal IT resources to build similar connectivity in-house. DrFirst has not disclosed total revenue or recurring revenue publicly. Headcount estimates for healthcare IT firms of its vintage and apparent scale typically range between 200 and 500 professionals, though no verified figure is available. The firm maintains its headquarters in Rockville, Maryland, with no publicly disclosed additional offices. DrFirst's institutional capital backers have included Georgian Partners and Goldman Sachs, with a growth equity minority investment announced in May 2021 (per the firm, May 2021). Adjacent vehicles include DrFirst's partnership with Surescripts, a competing health information network, with whom DrFirst has alternately competed and collaborated on medication history and prior authorization workflows. May 2021: DrFirst announced a minority growth investment from Goldman Sachs' Merchant Banking Division to scale its medication management and clinical collaboration platforms (per the firm, May 2021). DrFirst's structural differentiator is its embedded-network model: by integrating its clinical middleware directly into existing EHR and pharmacy systems rather than offering a standalone portal, the firm converts clinical inertia into a distributed revenue architecture. This design means DrFirst competes less with the EHR vendors themselves and more with point-solution communication startups that must convince clinicians to open a separate application — a behavioral hurdle DrFirst has spent over two decades systematically avoiding.